Atlas Trials

Microbiota Analysis to Predict Outcomes of Rheumatoid Arthritis Patients Treated With JAK-inhibitor

Clinical trial NCT04530305 · UNKNOWN

Trial details

NCT number
NCT04530305
Sponsor
University Hospital, Montpellier
Status
UNKNOWN
Study type
OBSERVATIONAL
Rheumatoid Arthritis
Start date
2021-01-07
Primary completion
2024-04-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.